TY - JOUR
T1 - Modulation of GABAergic dysfunction due to SCN1A mutation linked to Hippocampal Sclerosis
AU - Ruffolo, Gabriele
AU - Martinello, Katiuscia
AU - Labate, Angelo
AU - Cifelli, Pierangelo
AU - Fucile, Sergio
AU - di Gennaro, Giancarlo
AU - Quattrone, Andrea
AU - Esposito, Vincenzo
AU - Limatola, Cristina
AU - Giangaspero, Felice
AU - Aronica, Eleonora
AU - Palma, Eleonora
AU - Gambardella, Antonio
PY - 2020/9/1
Y1 - 2020/9/1
N2 - We compared GABAergic function and neuronal excitability in the hippocampal tissue of seven sporadic MTLE patients with a patient carrying a SCN1A loss-of-function mutation. All had excellent outcome from anterior temporal lobectomy, and neuropathological study always showed characteristic hippocampal sclerosis (Hs). Compared to MTLE patients, there was a more severe impairment of GABAergic transmission, due to the lower GABAergic activity related to the NaV1.1 loss-of-function, in addition to the typical GABA-current rundown, a hallmark of sporadic MTLE. Our results give evidence that a pharmacological rescuing of the GABAergic dysfunction may represent a promising strategy for the treatment of these patients.
AB - We compared GABAergic function and neuronal excitability in the hippocampal tissue of seven sporadic MTLE patients with a patient carrying a SCN1A loss-of-function mutation. All had excellent outcome from anterior temporal lobectomy, and neuropathological study always showed characteristic hippocampal sclerosis (Hs). Compared to MTLE patients, there was a more severe impairment of GABAergic transmission, due to the lower GABAergic activity related to the NaV1.1 loss-of-function, in addition to the typical GABA-current rundown, a hallmark of sporadic MTLE. Our results give evidence that a pharmacological rescuing of the GABAergic dysfunction may represent a promising strategy for the treatment of these patients.
UR - http://www.scopus.com/inward/record.url?scp=85089094425&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/acn3.51150
DO - https://doi.org/10.1002/acn3.51150
M3 - Article
C2 - 32761786
SN - 2328-9503
VL - 7
SP - 1726
EP - 1731
JO - Annals of clinical and translational neurology
JF - Annals of clinical and translational neurology
IS - 9
ER -